ForteBio Revenue and Competitors
Estimated Revenue & Valuation
- ForteBio's estimated annual revenue is currently $5.7M per year.
- ForteBio received $25.0M in venture funding in September 2008.
- ForteBio's estimated revenue per employee is $77,500
- ForteBio's total funding is $42.3M.
Employee Data
- ForteBio has 74 Employees.
- ForteBio grew their employee count by -5% last year.
ForteBio's People
Name | Title | Email/Phone |
---|---|---|
1 | Quality Control Associate | Reveal Email/Phone |
2 | Principal Product Development Engineer | Reveal Email/Phone |
3 | Senior Mechanical Engineer | Reveal Email/Phone |
ForteBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.8M | 102 | -3% | $38.1M | N/A |
What Is ForteBio?
EMPOWER THE DEVELOPMENT OF VITAL BIOLOGICS THAT CURE DISEASES. ForteBio is a business unit of Molecular Devices LLC based in Fremont, CA. We offer products that span multiple technology vectors including analytical instrumentation and software, clone picking and imaging, and, automation and customization engineering solutions. We develop and supply products for biomolecular analysis, including real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. Our solutions for antibody discovery and cell line development provide dedicated, scalable, and easy-to-use products for establishing clonal populations. The systems feature a selection of options and models to address your specific research including multiple imaging modes, biology-specific pins, fluidics, and environmental control. These solutions combine intelligent imaging with analysis and automation to increase throughput, consistency, and provide image-based documentation.
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals$42.3M
Total Funding
74
Number of Employees
$5.7M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ForteBio News
87G7 (21 nM) was loaded onto Protein A biosensors (ForteBio) for 10 min. Antigen binding was performed by incubating the biosensor with...
... a label-free detection system for molecular interaction analysis based on the principle of optical interference developed by ForteBio.
Agilent Technologies, Attana, Biacore, ForteBio, Perkin Elmer, F. Hoffman La Roche. This comprehensive Label-free Array Systems Market...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10M | 74 | 7% | N/A |
#2 | $22M | 74 | -3% | N/A |
#3 | $9.3M | 74 | 4% | $16.3M |
#4 | $14.9M | 74 | 9% | N/A |
#5 | $19.4M | 75 | 9% | N/A |
ForteBio Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2005-10-27 | $17.3M | B | Vertical Group | Article |
2008-09-24 | $25.0M | C | OrbiMed Advisors | Article |